RS

Ravindra Shapeti

Active Director Director DIN 00321634
DIN 00321634 First appointment Jun 1991 Primary industry Chemicals and Materials
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Jun 1991
Shareholding value •••• Premium profile

About Ravindra Shapeti

Data last updated:

Ravindra Shapeti is a Director at Rupak Enterprises Private Limited (since 1997), Director at Rupak Consultants Private Limited (since 1991) and Director at Apeksha Research Centre Pvt Ltd (since 1993). The companies operate in Chemicals and Materials, Pharma and Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹82.5 Lakh; the largest is Rupak Enterprises Private Limited at ₹40 Lakh (FY 2025). Earlier, Ravindra Shapeti was a Whole-Time Director at Symbiotec Pharmalab Limited (2010–2013) and Additional Director at Psa Chemicals And Pharmaceuticals Pvt Ltd (2017).

DIN 00321634
Primary Designation Director
Industry Chemicals and Materials
First Appointment 13 Jun 1991
Oldest Company Age 35 yrs
Largest company Rupak Enterprises Private Limited · ₹40 Lakh (FY 2025)
Combined revenue ₹82.5 Lakh across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rupak Enterprises Private Limited U74140MP1997PTC012240
Director21 Aug 19971997₹40 Lakh (FY 2025)Active
Rupak Consultants Private Limited U02423MP1991PTC006512
Director13 Jun 19911991₹36 Lakh (FY 2022)Active
Apeksha Research Centre Pvt Ltd U80302MP1993PTC007886
Director23 Sep 19931993₹6.5 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Symbiotec Pharmalab Limited U24232MP2002PLC015293
Whole-Time Director01 Dec 20102002₹756 Cr (FY 2025)Active
Additional Director25 Mar 20171992₹30.31 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Ravindra Shapeti

NameDINCompanyDesignation
Victor Cummings10416997Rupak Enterprises Private Limited , Rupak Consultants Private Limited and 1 moreDirector

Directorship timeline

Open interactive timeline →
Rupak Consultants Private Limited
Rupak Enterprises Private Limited
Apeksha Research Centre Pvt Ltd
Symbiotec Pharmalab Limited
Premium access

Shareholding and investment profile for Ravindra Shapeti

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravindra Shapeti

Ravindra Shapeti currently holds 3 directorships: Rupak Enterprises Private Limited (Director, since 21 Aug 1997, revenue ₹40 Lakh (FY 2025)); Rupak Consultants Private Limited (Director, since 13 Jun 1991, revenue ₹36 Lakh (FY 2022)); Apeksha Research Centre Pvt Ltd (Director, since 23 Sep 1993, revenue ₹6.5 Lakh (FY 2025)).

Ravindra Shapeti was first appointed on 13 Jun 1991 as Director at Rupak Consultants Private Limited. The most recent appointment on record is 25 Mar 2017 at Psa Chemicals And Pharmaceuticals Pvt Ltd.

The 3 current companies of Ravindra Shapeti that report revenue have a combined latest revenue of ₹82.5 Lakh: Rupak Enterprises Private Limited ₹40 Lakh (FY 2025); Rupak Consultants Private Limited ₹36 Lakh (FY 2022); Apeksha Research Centre Pvt Ltd ₹6.5 Lakh (FY 2025).

Ravindra Shapeti held 2 earlier board appointments: Symbiotec Pharmalab Limited (Whole-Time Director, 01 Dec 2010 to 21 Oct 2013); Psa Chemicals And Pharmaceuticals Pvt Ltd (Additional Director, 25 Mar 2017 to 21 Aug 2017).

The current boards of Ravindra Shapeti's companies include Victor Cummings (Rupak Enterprises Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available